Biopharmaceutical Process Analytical Technology Market

Report Code AST 9019
Published in May, 2024, By MarketsandMarkets™
Download PDF

Choose License Type

Buy Report Now Inquire Before Buying

Biopharmaceutical Process Analytical Technology Market Size by Technology (LC, GC, MS, qPCR, NGS, NMR, Raman, IR Spectroscopy), Product (Analyzer, Sensor, Software), Application (Vaccine, Biologics, CGT), and End User - Global Forecast to 2029

Overview

The size of global biopharmaceutical process analytical technology market in terms of revenue was estimated to be worth $1.2 billion in 2024 and is poised to reach $2.6 billion by 2029, growing at a CAGR of 16.0% from 2024 to 2029. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. The market is witnessing a surge in growth propelled by rising investments, both direct and indirect, in analytical instruments, coupled with strategic partnerships aimed at advancing drug discovery. Furthermore, the global biosimilar sector is on an upward trajectory, driven by these factors alongside the increasing number of conferences and symposia dedicated to analytical technologies. Looking forward, emerging markets are expected to offer promising opportunities for industry players in the coming five years.

Attractive Opportunities in the Biopharmaceutical Process Analytical Technology Market

Asia Pacific

The growth of the Asia Pacific market can be attributed to favorable conditions, improvements in infrastructure, ongoing regulatory advancements, and rising levels of manufacturing activity.

The expansion of the market is connected to research and development spending by biopharmaceutical firms, in addition to investments from government entities.

The growing adoption of analytical instruments in bioprocessing, spanning both research and manufacturing sectors, accounts for a substantial portion of the North American market

There are promising growth prospects in emerging markets such as China, Brazil, and India for businesses and investors looking for attractive opportunities in the anticipated market.

The process analytical market in the Asia Pacific region is witnessing unprecedented growth, with technology playing a crucial role in fueling its expansion.

Global Biopharmaceutical Process Analytical Technology Market Dynamics

Driver: Increasing demand for enhancing the quality of manufacturing processes

PAT instruments are sturdy instruments utilized for analyzing and managing Critical Quality Attributes (CQAs) within biopharmaceutical manufacturing workflows by assessing Critical Process Parameters (CPPs). These instruments play a pivotal role in enhancing production efficiency, ensuring top-notch product quality, and enhancing overall product performance. Through PAT, continuous monitoring of biopharmaceutical manufacturing is enabled, furnishing real-time insights into product quality and mitigating the need for batch reprocessing or disposal. This technology not only facilitates cost control but also accelerates product release by circumventing post-production testing, thereby offering financial advantages. Moreover, it diminishes cycle times and energy consumption associated with equipment operation. Automation within the process further trims labor expenses, contributing to overall cost savings.

Restraint: High cost of PAT deployment

Technological advancements have led to an escalation in the prices of various systems. For example, the price range for a new spectroscopy instrument is between USD 75,000 and USD 500,000. An HPLC system can cost anywhere from USD 10,000 to USD 40,000, while a dynamic light-scattering particle size analyzer may be priced in the range of USD 30,000 to USD 60,000, depending on accompanying accessories. Despite the operational advantages and potential cost savings associated with implementing Process Analytical Technology (PAT) in the biopharmaceutical sector, its uptake has been sluggish in emerging markets.

 

Opportunity: Healthcare costs are on the rise in developing nations

Emerging markets across Asia, including China, South Korea, Indonesia, and India, are poised to offer significant growth prospects for Process Analytical Technology (PAT). This is primarily driven by more lenient regulatory frameworks, a rising number of biopharmaceutical firms, a skilled workforce, and governmental efforts to bolster local manufacturing. Specifically, China and India represent key opportunities for PAT market expansion. These nations exhibit substantial demand for devices like spectrometers and chromatography instruments, driven by the establishment of new projects across various industries. Moreover, the robust biopharmaceutical sectors in China and India are expected to notably contribute to the growth of spectroscopy and chromatography markets in the foreseeable future.

Challenge: Lack of skilled professionals

The biopharmaceutical industry faces challenges due to a lack of skilled professionals in the field of process analytical technology (PAT). PAT involves the use of advanced analytical tools and techniques to monitor and control biopharmaceutical manufacturing processes in real time. The shortage of skilled professionals in PAT can hinder the implementation and optimization of these technologies, leading to inefficiencies in manufacturing processes, increased costs, and potential delays in bringing new therapies to market. Addressing this shortage requires investment in education and training programs to develop the necessary expertise in PAT among scientists, engineers, and technicians within the biopharmaceutical industry.

Global Biopharmaceutical Process Analytical Technology Market Ecosystem Analysis

 

 

By type, the mass spectrometry segment of the biopharmaceutical process analytical technology industry accounted for the largest share in 2024.

Based on type, the biopharmaceutical process analytical technology market is segmented into liquid chromatography/HPLC, GAS chromatography, mass spectrometry, real-time PCR/QPCR, NGS, NMR spectroscopy, raman spectroscopy, infrared spectroscopy, particle counters and imaging, differential light scattering, and other techniques. In 2024, the liquid chromatography/HPLC segment accounted for the largest market share. Liquid chromatography is essential for gathering quantitative data in drug development, particularly regarding pharmacokinetics and pharmacodynamics, in conjunction with chromatography. Its widespread use in both qualitative and quantitative analyses of pharmaceutical and biopharmaceutical products is anticipated to drive substantial growth in the spectroscopy sector in the foreseeable future.

By product type, the analyzers segment of the biopharmaceutical process analytical technology industry accounted for the largest share during the forecast period.

Biopharmaceutical process analytical products include analyzers, sensors & probes, samplers, and software. In 2023, the analyzer segment accounted for the largest share of the biopharmaceutical process analytical technology market. The need for analyzers in pharmaceutical production is mainly driven by the necessity for smoother and more effective manufacturing procedures, strict regulations guaranteeing product quality and performance, and the increasing amount of research and development initiatives within the biopharmaceutical industry.

North America region holds the largest share of the Biopharmaceutical Process Analytical Technology Market.

North America, comprising the US and Canada, accounted for the largest share of the biopharmaceutical process analytical technology market in 2023. The significant growth of the North American market can largely be attributed to the strict FDA regulations overseeing drug approval and safety, the strong presence of pharmaceutical companies, and the swift adoption of cutting-edge technologies. Other factors contributing to the market's expansion in North America include increased investment in biotechnology research and a growing demand for biologics.

 
 

Recent Developments of Biopharmaceutical Process Analytical Technology Market industry

  • In Feb 2024, Thermo Fisher Scientific Inc. introduced the Thermo Scientific Dionex Inuvion Ion Chromatography (IC) system, aimed at simplifying, and enhancing ion analysis across laboratories of varying scales. This innovative analytical instrument offers easy reconfiguration, serving as a comprehensive solution for the precise determination of ionic and small polar compounds, ensuring consistent and reliable results.
  • In April 2022, Thermo Fisher Scientific Inc. has introduced the Ramina Process Analyzer, a Raman spectroscopic analyzer aimed at simplifying Raman spectroscopy measurements to enhance user accessibility by reducing complexity.

Key Market Players

KEY PLAYERS IN THE Biopharmaceutical Process Analytical Technology Market INCLUDE

Want to explore hidden markets that can drive new revenue in Biopharmaceutical Process Analytical Technology Market?

Scope of the Report

Report Attribute Details
Market Revenue in 2024 $1.2 billion
Projected Revenue by 2029 $2.6 billion
Revenue Rate Poised to Grow at a CAGR of 16.0%
Market Driver Increasing demand for enhancing the quality of manufacturing processes
Market Opportunity Healthcare costs are on the rise in developing nations

 

Key Questions Addressed by the Report

What is the projected market revenue value of the global biopharmaceutical process analytical technology market?
The global biopharmaceutical process analytical technology market is projected to reach a total revenue value of $2.6 billion by 2029.
What is the estimated growth rate (CAGR) of the global biopharmaceutical process analytical technology market?
The market is expected to grow at a CAGR of 16.0% with a revenue size of approximately $1.2 billion by 2024.

 

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Biopharmaceutical Process Analytical Technology Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
INTRODUCTION
22
RESEARCH METHODOLOGY
27
EXECUTIVE SUMMARY
39
PREMIUM INSIGHTS
43
MARKET OVERVIEW
46
  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    DRIVERS
    - Rising R&D investments by pharma companies and governments in emerging markets
    - Growing incidence of infectious diseases and essential contribution of PAT in vaccine development
    - Requirement for improved efficiency in manufacturing processes driving enhancements in quality
    - Advancements in analytical device technology
    RESTRAINTS
    - High cost of process analytical technology deployment
    - Governmental regulations pertaining to safety of drugs
    OPPORTUNITIES
    - Increasing interest in PAT in emerging markets
    - Increasing utilization of analytical instruments in biopharmaceutical processes
    CHALLENGES
    - Lack of skilled professionals
  • 5.3 REGULATORY ANALYSIS
    REGULATORY LANDSCAPE
    KEY REGULATORY BODIES & GOVERNMENT AGENCIES
    KEY REGULATORY GUIDELINES
    - US
    - Europe
    - Asia Pacific
    - Rest of the World
  • 5.4 VALUE CHAIN ANALYSIS
  • 5.5 SUPPLY CHAIN ANALYSIS
    PROMINENT COMPANIES
    SMALL AND MEDIUM-SIZED ENTERPRISES
    END USERS
  • 5.6 ECOSYSTEM ANALYSIS
  • 5.7 INVESTMENT & FUNDING SCENARIO
  • 5.8 PRICING ANALYSIS
  • 5.9 TRADE ANALYSIS
    IMPORT DATA
    EXPORT DATA
  • 5.10 PATENT ANALYSIS
    PATENT DETAILS FOR BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY (JANUARY 2013–DECEMBER 2023)
  • 5.11 PORTER’S FIVE FORCE ANALYSIS
    THREAT OF NEW ENTRANTS
    THREAT OF SUBSTITUTES
    BARGAINING POWER OF SUPPLIERS
    BARGAINING POWER OF BUYERS
    INTENSITY OF COMPETITIVE RIVALRY
  • 5.12 KEY CONFERENCES & EVENTS
  • 5.13 CASE STUDY ANALYSIS
    NAVIGATING DIGITAL TRANSFORMATION: INTEGRATING ADVANCED TECHNOLOGIES FOR PAT IN BIOPHARMACEUTICAL MANUFACTURING.
    - Case 1: Advancements in process analytical technology
  • 5.14 TECHNOLOGY ANALYSIS
    KEY TECHNOLOGIES
    - Mass spectrometry (MS)
    - Liquid chromatography/HPLC
    COMPLEMENTARY TECHNOLOGIES
    - Advanced sensor technologies
    ADJACENT TECHNOLOGIES
    - Bioprocess monitoring and control systems
  • 5.15 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
  • 5.16 KEY STAKEHOLDERS & BUYING CRITERIA
    KEY STAKEHOLDERS IN BUYING PROCESS
    BUYING CRITERIA
  • 5.17 UNMET NEEDS AND KEY PAIN POINTS
BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET, BY TYPE
75
  • 6.1 INTRODUCTION
  • 6.2 LIQUID CHROMATOGRAPHY/HPLC
    EARLY AND EFFICIENT SAMPLE ANALYSIS ASSOCIATED WITH LC TO DRIVE MARKET GROWTH
  • 6.3 GAS CHROMATOGRAPHY
    GROWING ADOPTION OF COMPACT GC SYSTEMS IN MANUFACTURING FACILITIES TO BOLSTER GROWTH
  • 6.4 MASS SPECTROMETRY
    GROWING NEED FOR DUAL-MASS ANALYZERS TO PROPEL GROWTH
  • 6.5 REAL-TIME PCR/QPCR
    EXPANSION OF PCR INSTRUMENTATION TO FAVOR MARKET GROWTH
  • 6.6 NEXT-GENERATION SEQUENCING
    INCREASING INVESTMENTS IN NEXT-GENERATION SEQUENCING (NGS) TECHNOLOGIES TO DRIVE MARKET EXPANSION
  • 6.7 NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY
    ADVANCING BIOPHARMACEUTICAL QUALITY AND EFFICIENCY THROUGH NMR SPECTROSCOPY TO BOOST MARKET
  • 6.8 RAMAN SPECTROSCOPY
    EXPANDING ROLE OF RAMAN SPECTROSCOPY IN PROCESS MONITORING AND QUALITY CONTROL TO BOOST MARKET
  • 6.9 INFRARED SPECTROSCOPY
    INCREASING UTILIZATION OF MINIATURIZED GC SYSTEMS IN PRODUCTION PLANTS TO SUPPORT GROWTH
  • 6.10 PARTICLE COUNTERS & IMAGING
    INCREASING DEMAND FOR HIGH-QUALITY MEDICATIONS WITH REDUCED SIDE EFFECTS TO FACILITATE MARKET ACCEPTANCE
  • 6.11 DIFFERENTIAL LIGHT SCATTERING
    CONTROLLED MANUFACTURING OF PHARMACEUTICALS WITH FEWER SIDE EFFECTS TO BOOST ADOPTION
  • 6.12 OTHER TECHNIQUES
BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET, BY PRODUCT TYPE
101
  • 7.1 INTRODUCTION
  • 7.2 ANALYZERS
    TECHNOLOGICAL ADVANCEMENTS TO SUPPORT MARKET GROWTH
  • 7.3 SENSORS & PROBES
    QUICK TURNAROUND TIMES AND AUTOMATED PROCESSES TO FACILITATE MARKET ADOPTION
  • 7.4 SAMPLERS
    HIGH LEVEL OF ACCURACY AND REPRODUCIBILITY TO DRIVE MARKET GROWTH
  • 7.5 SOFTWARE
    GROWING ADOPTION OF PAT FRAMEWORKS WITHIN PHARMACEUTICAL COMPANIES TO BOLSTER ADOPTION
BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET, BY MODE
108
  • 8.1 INTRODUCTION
  • 8.2 ONLINE MEASUREMENT
    IMPROVED PROCESS EFFICIENCY AND REDUCED PRODUCTION COSTS TO BOOST ADOPTION
  • 8.3 OFFLINE MEASUREMENT
    HIGH FLEXIBILITY OF OFFLINE ANALYSIS TO DRIVE GROWTH
  • 8.4 AT-LINE MEASUREMENT
    GROWING USE OF AT-LINE MEASUREMENT TO BOOST MARKET GROWTH
  • 8.5 IN-LINE MEASUREMENT
    FAST TURNAROUND TIME TO BOOST SEGMENTAL GROWTH
BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET, BY APPLICATION
114
  • 9.1 INTRODUCTION
  • 9.2 VACCINES
    GROWING PREVALENCE OF INFECTIOUS DISEASES TO DRIVE MARKET GROWTH FOR VACCINES
  • 9.3 CELL & GENE THERAPY
    GROWING DEMAND FOR STEM CELL AND CAR-T THERAPIES TO BOOST MARKET GROWTH
  • 9.4 BIOSIMILARS & BIOLOGICS
    HIGH LEVELS OF ACCURACY AND REPRODUCIBILITY TO PROPEL DEMAND FOR BIOSIMILARS & BIOLOGICS
  • 9.5 HORMONAL THERAPY
    IMPROVING CANCER TREATMENT WITH ADVANCED HORMONAL THERAPY TO FAVOR MARKET GROWTH
  • 9.6 OTHER APPLICATIONS
BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET, BY REGION
122
  • 10.1 INTRODUCTION
  • 10.2 NORTH AMERICA
    NORTH AMERICA: RECESSION IMPACT
    US
    - Stringent regulations and dominance of pharma and biopharma firms to propel market growth
    CANADA
    - Widespread occurrence of cancer and promising funding landscape to bolster market growth
  • 10.3 EUROPE
    EUROPE: RECESSION IMPACT
    GERMANY
    - Growing adoption of biopharmaceutical process analytical technology (PAT) to propel market
    FRANCE
    - Infrastructure development and increasing life science R&D investment to propel growth
    UK
    - Government initiatives to boost market expansion
    ITALY
    - Conducive funding environment in Italy to boost market
    SPAIN
    - Growing focus on cancer screening and digital health initiatives to boost market
    REST OF EUROPE
  • 10.4 ASIA PACIFIC
    ASIA PACIFIC: RECESSION IMPACT
    JAPAN
    - Advanced infrastructure to support market growth in Japan
    CHINA
    - Growing demand for PAT to boost market
    INDIA
    - Growing biopharmaceutical industry to drive market growth
    AUSTRALIA
    - Government investments to propel market growth
    SOUTH KOREA
    - Extensive insurance coverage to boost market growth
    REST OF ASIA PACIFIC
  • 10.5 LATIN AMERICA
    LATIN AMERICA: RECESSION IMPACT
    BRAZIL
    - Expansion within biopharmaceutical sector to contribute to market growth
    MEXICO
    - Growing exports of biopharmaceuticals to drive market in Mexico
    REST OF LATIN AMERICA
  • 10.6 MIDDLE EAST & AFRICA
    MIDDLE EAST & AFRICA: RECESSION IMPACT
COMPETITIVE LANDSCAPE
161
  • 11.1 OVERVIEW
  • 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET
  • 11.3 REVENUE ANALYSIS
  • 11.4 MARKET SHARE ANALYSIS
  • 11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS
    STARS
    EMERGING LEADERS
    PERVASIVE PLAYERS
    PARTICIPANTS
    COMPANY FOOTPRINT: KEY PLAYERS
  • 11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES
    PROGRESSIVE COMPANIES
    RESPONSIVE COMPANIES
    DYNAMIC COMPANIES
    STARTING BLOCKS
    COMPETITIVE BENCHMARKING
  • 11.7 COMPANY VALUATION & FINANCIAL METRICS
  • 11.8 BRAND/PRODUCT COMPARISON
  • 11.9 COMPETITIVE SCENARIO
    PRODUCT LAUNCHES
    DEALS
    EXPANSIONS
COMPANY PROFILES
183
  • 12.1 KEY PLAYERS
    WATERS CORPORATION
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    DANAHER CORPORATION
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    THERMO FISHER SCIENTIFIC INC.
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    AGILENT TECHNOLOGIES, INC.
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    SHIMADZU CORPORATION
    - Business overview
    - Products offered
    - Recent developments
    PERKINELMER, INC.
    - Business overview
    - Products offered
    - Recent developments
    BRUKER CORPORATION
    - Business overview
    - Products offered
    - Recent developments
    METTLER-TOLEDO INTERNATIONAL INC.
    - Business overview
    - Products offered
    - Recent developments
    CARL ZEISS AG (ZEISS GROUP)
    - Business overview
    - Products offered
    EMERSON ELECTRIC CO.
    - Business overview
    - Products offered
    ABB
    - Business overview
    - Products offered
    - Recent developments
    SARTORIUS AG
    - Business overview
    - Products offered
    - Recent developments
    PROCESS INSIGHTS, INC.
    - Business overview
    - Products offered
    MERCK KGAA
    - Business overview
    - Products offered
    - Recent developments
    VERUM ANALYTICS, LLC
    - Business overview
    - Products offered
  • 12.2 OTHER PLAYERS
    HAMILTON COMPANY
    ENDRESS+HAUSER GROUP SERVICES AG
    VIAVI SOLUTIONS INC.
    METROHM AG
    CONTROL DEVELOPMENT, INC.
    NECI
    SCHMIDT + HAENSCH
    SENSUM D.O.O.
    AMETEK, INC.
    SENTRONIC GMBH
APPENDIX
240
  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
  • 13.3 CUSTOMIZATION OPTIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS
LIST OF TABLES
 
  • TABLE 1 REGULATORY STANDARDS/APPROVALS REQUIRED FOR PROCESS ANALYTICAL TECHNOLOGY, BY COUNTRY/REGION
  • TABLE 2 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 3 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 4 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 5 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 6 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 7 BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET: ROLE IN ECOSYSTEM
  • TABLE 8 AVERAGE SELLING PRICE OF PROCESS ANALYTICAL TECHNOLOGIES, BY REGION, 2021–2023 (USD THOUSAND)
  • TABLE 9 IMPORT DATA FOR CHROMATOGRAPHY SYSTEMS (HS CODE 902720), BY COUNTRY, 2019–2023 (USD THOUSAND)
  • TABLE 10 IMPORT DATA FOR SPECTROMETERS, SPECTROPHOTOMETERS, AND SPECTROGRAPHS (HS CODE 902730), BY COUNTRY, 2019–2023 (USD THOUSAND)
  • TABLE 11 EXPORT DATA FOR CHROMATOGRAPHY SYSTEMS (HS CODE 902720), BY COUNTRY, 2019–2023 (USD THOUSAND)
  • TABLE 12 EXPORT DATA FOR SPECTROMETERS, SPECTROPHOTOMETERS, AND SPECTROGRAPHS (HS CODE 902730), BY COUNTRY, 2019–2023 (USD THOUSAND)
  • TABLE 13 BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET: PORTER’S FIVE FORCES ANALYSIS
  • TABLE 14 LIST OF MAJOR CONFERENCES & EVENTS IN BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET IN JANUARY 2024-DECEMBER 2024
  • TABLE 15 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS (%)
  • TABLE 16 KEY BUYING CRITERIA FOR PROCESS ANALYTICAL TECHNOLOGY
  • TABLE 17 BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET: CURRENT UNMET NEEDS
  • TABLE 18 BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 19 BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET VOLUME, BY TYPE, 2022–2029 (MILLION UNITS)
  • TABLE 20 BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 21 DIFFERENTIATION OF LIQUID CHROMATOGRAPHY SYSTEMS
  • TABLE 22 BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET FOR LIQUID CHROMATOGRAPHY/HPLC, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 23 BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET FOR LIQUID CHROMATOGRAPHY/HPLC, BY MODE, 2022–2029 (USD MILLION)
  • TABLE 24 BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET FOR LIQUID CHROMATOGRAPHY/HPLC, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 25 BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET FOR GAS CHROMATOGRAPHY, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 26 BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET FOR GAS CHROMATOGRAPHY, BY MODE, 2022–2029 (USD MILLION)
  • TABLE 27 BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET FOR GAS CHROMATOGRAPHY, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 28 BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET FOR MASS SPECTROMETRY, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 29 BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET FOR MASS SPECTROMETRY, BY MODE, 2022–2029 (USD MILLION)
  • TABLE 30 BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET FOR MASS SPECTROMETRY, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 31 BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET FOR REAL-TIME PCR/QPCR, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 32 BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET FOR REAL-TIME PCR/QPCR, BY MODE, 2022–2029 (USD MILLION)
  • TABLE 33 BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET FOR REAL-TIME PCR/QPCR, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 34 BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET FOR NEXT-GENERATION SEQUENCING, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 35 BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET FOR NEXT-GENERATION SEQUENCING, BY MODE, 2022–2029 (USD MILLION)
  • TABLE 36 BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET FOR NEXT-GENERATION SEQUENCING, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 37 BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET FOR NMR SPECTROSCOPY, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 38 BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET FOR NMR SPECTROSCOPY, BY MODE, 2022–2029 (USD MILLION)
  • TABLE 39 BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET FOR NMR SPECTROSCOPY, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 40 BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET FOR RAMAN SPECTROSCOPY, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 41 BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET FOR RAMAN SPECTROSCOPY, BY MODE, 2022–2029 (USD MILLION)
  • TABLE 42 BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET FOR RAMAN SPECTROSCOPY, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 43 BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET FOR INFRARED SPECTROSCOPY, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 44 BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET FOR INFRARED SPECTROSCOPY, BY MODE, 2022–2029 (USD MILLION)
  • TABLE 45 BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET FOR INFRARED SPECTROSCOPY, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 46 BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET FOR PARTICLE COUNTERS & IMAGING, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 47 BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET FOR PARTICLE COUNTERS & IMAGING, BY MODE, 2022–2029 (USD MILLION)
  • TABLE 48 BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET FOR PARTICLE COUNTERS & IMAGING, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 49 BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET FOR DIFFERENTIAL LIGHT SCATTERING, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 50 BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET FOR DIFFERENTIAL LIGHT SCATTERING, BY MODE, 2022–2029 (USD MILLION)
  • TABLE 51 BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET FOR DIFFERENTIAL LIGHT SCATTERING, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 52 BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET FOR OTHER TECHNIQUES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 53 BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET FOR OTHER TECHNIQUES, BY MODE, 2022–2029 (USD MILLION)
  • TABLE 54 BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET FOR OTHER TECHNIQUES, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 55 BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET, BY PRODUCT TYPE, 2022–2029 (USD MILLION)
  • TABLE 56 BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET FOR ANALYZERS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 57 BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET FOR SENSORS & PROBES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 58 BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET FOR SAMPLERS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 59 BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET FOR SOFTWARE, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 60 COMPARISON BETWEEN MEASUREMENT METHODS IN PAT
  • TABLE 61 BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET, BY MODE, 2022–2029 (USD MILLION)
  • TABLE 62 BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET FOR ONLINE MEASUREMENT, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 63 BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET FOR OFFLINE MEASUREMENT, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 64 BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET FOR AT-LINE MEASUREMENT, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 65 BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET FOR IN-LINE MEASUREMENT, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 66 BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 67 BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET FOR VACCINES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 68 BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET FOR CELL & GENE THERAPY, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 69 BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET FOR BIOSIMILARS & BIOLOGICS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 70 BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET FOR HORMONAL THERAPY, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 71 BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET FOR OTHER APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 72 BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 73 NORTH AMERICA: BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 74 NORTH AMERICA: BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 75 NORTH AMERICA: BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET, BY MODE, 2022–2029 (USD MILLION)
  • TABLE 76 NORTH AMERICA: PROCESS ANALYTICAL TECHNOLOGY MARKET, BY PRODUCT TYPE, 2022–2029 (USD MILLION)
  • TABLE 77 NORTH AMERICA: BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 78 US: BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 79 CANADA: BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 80 EUROPE: BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 81 EUROPE: BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 82 EUROPE: BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET, BY MODE, 2022–2029 (USD MILLION)
  • TABLE 83 EUROPE: PROCESS ANALYTICAL TECHNOLOGY MARKET, BY PRODUCT TYPE, 2022–2029 (USD MILLION)
  • TABLE 84 EUROPE: BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 85 GERMANY: BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 86 FRANCE: BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 87 UK: BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 88 ITALY: BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 89 SPAIN: BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 90 REST OF EUROPE: BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 91 ASIA PACIFIC: BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 92 ASIA PACIFIC: BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 93 ASIA PACIFIC: BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET, BY MODE, 2022–2029 (USD MILLION)
  • TABLE 94 ASIA PACIFIC: PROCESS ANALYTICAL TECHNOLOGY MARKET, BY PRODUCT TYPE, 2022–2029 (USD MILLION)
  • TABLE 95 ASIA PACIFIC: BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 96 JAPAN: BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 97 CHINA: BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 98 INDIA: BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 99 AUSTRALIA: BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 100 SOUTH KOREA: BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 101 REST OF ASIA PACIFIC: BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 102 LATIN AMERICA: BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 103 LATIN AMERICA: BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 104 LATIN AMERICA: BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET, BY MODE, 2022–2029 (USD MILLION)
  • TABLE 105 LATIN AMERICA: PROCESS ANALYTICAL TECHNOLOGY MARKET, BY PRODUCT TYPE, 2022–2029 (USD MILLION)
  • TABLE 106 LATIN AMERICA: BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 107 BRAZIL: BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 108 MEXICO: BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 109 REST OF LATIN AMERICA: BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 110 MIDDLE EAST & AFRICA: BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 111 MIDDLE EAST & AFRICA: BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET, BY MODE, 2022–2029 (USD MILLION)
  • TABLE 112 MIDDLE EAST & AFRICA: PROCESS ANALYTICAL TECHNOLOGY MARKET, BY PRODUCT TYPE, 2022–2029 (USD MILLION)
  • TABLE 113 MIDDLE EAST & AFRICA: BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 114 OVERVIEW OF STRATEGIES ADOPTED BY KEY MANUFACTURING COMPANIES
  • TABLE 115 BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET: DEGREE OF COMPETITION
  • TABLE 116 BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET: PRODUCT FOOTPRINT
  • TABLE 117 BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET: REGIONAL FOOTPRINT
  • TABLE 118 BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET: DETAILED LIST OF KEY STARTUPS/SME PLAYERS
  • TABLE 119 BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS
  • TABLE 120 BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET: PRODUCT LAUNCHES, JANUARY 2020–MARCH 2024
  • TABLE 121 BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET: DEALS, JANUARY 2020–MARCH 2024
  • TABLE 122 BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET: EXPANSIONS, JANUARY 2020–APRIL 2024
  • TABLE 123 WATERS CORPORATION: COMPANY OVERVIEW
  • TABLE 124 WATERS CORPORATION: PRODUCTS OFFERED
  • TABLE 125 WATERS CORPORATION: DEALS
  • TABLE 126 DANAHER CORPORATION: COMPANY OVERVIEW
  • TABLE 127 DANAHER CORPORATION: PRODUCTS OFFERED
  • TABLE 128 DANAHER CORPORATION: DEALS
  • TABLE 129 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
  • TABLE 130 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED
  • TABLE 131 THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES
  • TABLE 132 THERMO FISHER SCIENTIFIC INC.: DEALS
  • TABLE 133 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW
  • TABLE 134 AGILENT TECHNOLOGIES, INC.: PRODUCTS OFFERED
  • TABLE 135 AGILENT TECHNOLOGIES, INC.: PRODUCT LAUNCHES
  • TABLE 136 AGILENT TECHNOLOGIES, INC.: DEALS
  • TABLE 137 SHIMADZU CORPORATION: COMPANY OVERVIEW
  • TABLE 138 SHIMADZU CORPORATION: PRODUCTS OFFERED
  • TABLE 139 SHIMADZU CORPORATION: PRODUCT LAUNCHES
  • TABLE 140 SHIMADZU CORPORATION: EXPANSIONS
  • TABLE 141 PERKINELMER, INC.: COMPANY OVERVIEW
  • TABLE 142 PERKINELMER, INC.: PRODUCTS OFFERED
  • TABLE 143 PERKINELMER, INC.: PRODUCT LAUNCHES
  • TABLE 144 BRUKER CORPORATION: COMPANY OVERVIEW
  • TABLE 145 BRUKER CORPORATION: PRODUCTS OFFERED
  • TABLE 146 BRUKER CORPORATION: PRODUCT LAUNCHES
  • TABLE 147 BRUKER CORPORATION: DEALS
  • TABLE 148 METTLER-TOLEDO INTERNATIONAL INC.: COMPANY OVERVIEW
  • TABLE 149 METTLER-TOLEDO INTERNATIONAL INC.: PRODUCTS OFFERED
  • TABLE 150 METTLER-TOLEDO INTERNATIONAL INC.: DEALS
  • TABLE 151 CARL ZEISS AG: COMPANY OVERVIEW
  • TABLE 152 CARL ZEISS AG: PRODUCTS OFFERED
  • TABLE 153 EMERSON ELECTRIC CO.: COMPANY OVERVIEW
  • TABLE 154 EMERSON ELECTRIC CO.: PRODUCTS OFFERED
  • TABLE 155 ABB: COMPANY OVERVIEW
  • TABLE 156 ABB: PRODUCTS OFFERED
  • TABLE 157 ABB: EXPANSIONS
  • TABLE 158 SARTORIUS AG: COMPANY OVERVIEW
  • TABLE 159 SARTORIUS AG: PRODUCTS OFFERED
  • TABLE 160 SARTORIUS AG: DEALS
  • TABLE 161 SARTORIUS AG: EXPANSIONS
  • TABLE 162 PROCESS INSIGHTS, INC.: COMPANY OVERVIEW
  • TABLE 163 PROCESS INSIGHTS, INC.: PRODUCTS OFFERED
  • TABLE 164 MERCK KGAA: COMPANY OVERVIEW
  • TABLE 165 MERCK KGAA: PRODUCTS OFFERED
  • TABLE 166 MERCK KGAA: DEALS
  • TABLE 167 VERUM ANALYTICS, LLC: COMPANY OVERVIEW
  • TABLE 168 VERUM ANALYTICS, LLC: PRODUCTS OFFERED
LIST OF FIGURES
 
  • FIGURE 1 RESEARCH DESIGN
  • FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
  • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
  • FIGURE 5 BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ESTIMATION)
  • FIGURE 6 BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
  • FIGURE 7 CAGR PROJECTION: SUPPLY-SIDE ANALYSIS
  • FIGURE 8 DATA TRIANGULATION METHODOLOGY
  • FIGURE 9 BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 10 BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET, BY PRODUCT TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 11 BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET, BY APPLICATION, 2024 VS. 2029
  • FIGURE 12 BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET: GEOGRAPHICAL SNAPSHOT
  • FIGURE 13 GROWING R&D EXPENDITURE BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES TO DRIVE MARKET GROWTH
  • FIGURE 14 ONLINE MEASUREMENT TO DOMINATE MARKET DURING FORECAST PERIOD
  • FIGURE 15 NORTH AMERICA TO HOLD LARGEST SHARE OF ALL APPLICATION SEGMENTS IN 2024
  • FIGURE 16 ASIA PACIFIC TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
  • FIGURE 17 BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 18 PHARMACEUTICAL R&D EXPENDITURE: ANNUAL GROWTH RATE (%)
  • FIGURE 19 BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 20 BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 21 BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 22 NUMBER OF INVESTOR DEALS, BY KEY PLAYER, 2018–2022
  • FIGURE 23 VALUE OF INVESTOR DEALS, BY KEY PLAYER, 2018–2022 (USD MILLION)
  • FIGURE 24 AVERAGE SELLING PRICE TREND OF MAJOR PROCESS ANALYTICAL TECHNOLOGIES, BY TYPE (USD THOUSAND)
  • FIGURE 25 AVERAGE SELLING PRICE TREND OF MAJOR PROCESS ANALYTICAL TECHNOLOGIES, BY REGION (USD THOUSAND)
  • FIGURE 26 REVENUE SHIFT IN BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET
  • FIGURE 27 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE CATEGORIES
  • FIGURE 28 KEY BUYING CRITERIA FOR PROCESS ANALYTICAL TECHNOLOGY
  • FIGURE 29 GLOBAL CANCER CASES, 202O VS. 2022
  • FIGURE 30 NORTH AMERICA: BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SNAPSHOT
  • FIGURE 31 ASIA PACIFIC: BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SNAPSHOT
  • FIGURE 32 REVENUE ANALYSIS OF TOP THREE PLAYERS IN BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET (2019–2023)
  • FIGURE 33 BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SHARE ANALYSIS OF KEY PLAYERS (2023)
  • FIGURE 34 BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • FIGURE 35 BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET: COMPANY FOOTPRINT
  • FIGURE 36 BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
  • FIGURE 37 EV/EBITDA OF KEY VENDORS
  • FIGURE 38 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 39 BRAND/PRODUCT COMPARATIVE ANALYSIS, BY MODEL
  • FIGURE 40 WATERS CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 41 DANAHER CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 42 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 43 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 44 SHIMADZU CORPORATION: COMPANY SNAPSHOT (2022)
  • FIGURE 45 PERKINELMER, INC.: COMPANY SNAPSHOT (2022)
  • FIGURE 46 BRUKER CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 47 METTLER-TOLEDO INTERNATIONAL INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 48 CARL ZEISS AG: COMPANY SNAPSHOT (2022)
  • FIGURE 49 EMERSON ELECTRIC CO.: COMPANY OVERVIEW
  • FIGURE 50 ABB: COMPANY SNAPSHOT (2023)
  • FIGURE 51 SARTORIUS AG: COMPANY SNAPSHOT (2023)
  • FIGURE 52 MERCK KGAA: COMPANY SNAPSHOT (2023)

The study involved four major activities in estimating the current size of the biopharmaceutical process analytical technology market. Exhaustive secondary research was done to collect information on the market, peer, and parent markets. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation were used to estimate the market size of segments and subsegments.

Secondary Research

The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial biopharmaceutical process analytical technology market study. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations in the biopharmaceutical process analytical technology market. The primary sources from the demand side include biopharmaceutical manufacturer companies, research organizations, academic institutes, and process analytical service providing companies, among others. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends & key market dynamics.

A breakdown of the primary respondents is provided below:

Biopharmaceutical Process Analytical  Technology Market Size, and Share

*Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

Note: Companies are classified into tiers based on their total revenue. As of 2023, Tier 1 = >USD 1,000 million, Tier 2 = USD 500–1,000 million, and Tier 3 = <USD 500 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Estimation Methodology

In this report, the global biopharmaceutical process analytical technology market's size was determined using the revenue share analysis of leading players. For this purpose, key players in the market were identified, and their revenues from the PAT business were determined through various insights gathered during the primary and secondary research phases. Secondary research included the study of the annual and financial reports of the top market players. In contrast, primary research included extensive interviews with key opinion leaders, such as CEOs, directors, and marketing executives.

To calculate the global market value, segmental revenues were calculated based on the revenue mapping of major solution/service providers. This process involved the following steps:

  • A list of major players operating in the biopharmaceutical process analytical technology market at the regional/country level
  • Product mapping of various manufacturers for each type of process analytical technology product at the regional/country level
  • Mapping of annual revenue generated by listed major players from PAT products segments (or the nearest reported business unit/product category)
  • Revenue mapping of major players to cover at least ~60% of the global market share as of 2023
  • Extrapolation of the revenue mapping of the listed major players to derive the global market value of the respective segments/subsegments
  • Summation of the market value of all segments/subsegments to arrive at the global process analytical technology market

Biopharmaceutical Process Analytical  Technology Market Size, and Share

To know about the assumptions considered for the study, Request for Free Sample Report

Data Triangulation

After arriving at the overall market size from the market size estimation process explained above, the global biopharmaceutical process analytical technology market was split into segments and subsegments. Data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from both the demand and supply sides. Additionally, the biopharmaceutical process analytical technology market was validated using both top-down and bottom-up approaches.

Market Definition

The biopharmaceutical process analytical technology (PAT) market encompasses the tools, techniques, and systems used to monitor, control, and optimize the manufacturing processes of biopharmaceuticals. It involves advanced analytical methods aimed at ensuring product quality, efficiency, and compliance in the production of biopharmaceutical drugs.

Key Stakeholders

  • Process analytical technology manufacturers, suppliers, and providers
  • Biopharmaceutical firms
  • Contract research and manufacturing organizations
  • Academic and private research institutions
  • Research and Development (R&D) Companies
  • Medical Research Laboratories
  • Academic institutions and private research institutions
  • Regulatory Agencies
  • Quality Control and Assurance
  • Contract Manufacturing Organizations (CMOs)
  • Environmental and Safety Regulatory Bodies
  • Public and Private Research Institutions
  • Third-party Testing Laboratories

Objectives of the Study

  • To define, describe, and forecast the biopharmaceutical process analytical technology market based on type, product type, mode, application, and region
  • To provide detailed information regarding the major factors influencing the growth potential of the global biopharmaceutical process analytical technology market (drivers, restraints, opportunities, challenges, and trends)
  • To analyze the micro markets with respect to individual growth trends, future prospects, and contributions to the global biopharmaceutical process analytical technology market
  • To analyze key growth opportunities in the global biopharmaceutical process analytical technology market for key stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of market segments and/or subsegments with respect to five major regions, namely, North America (US and Canada), Europe (Germany, France, the UK, Italy, Spain, and the RoE), Asia Pacific (Japan, China, India, and the RoAPAC), Latin America (Brazil, Mexico, and RoLATAM), and the Middle East & Africa
  • To profile the key players in the global biopharmaceutical process analytical technology market and comprehensively analyze their market shares and core competencies
  • To track and analyze the competitive developments undertaken in the global biopharmaceutical process analytical technology market, such as product launches; agreements; expansions; and mergers & acquisitions.

Available Customizations

With the given market data, MarketsandMarkets offers customizations per the company’s specific needs. The following customization options are available for the present x-ray detectors market report:

Product Analysis

  • Product matrix, which gives a detailed comparison of the product portfolios of the top five companies

Company Information

  • Detailed analysis and profiling of additional market players (up to five)

Geographic Analysis

  • Further breakdown of the Rest of Europe x-ray detectors market into Russia, Belgium, the Netherlands, Switzerland, Austria, Finland, Sweden, Poland, and Portugal, among others
  • Further breakdown of the Rest of Asia Pacific diagnostic imaging market into Singapore, Taiwan, New Zealand, Philippines, Malaysia, and other APAC countries

Previous Versions of this Report

"Our USP is "providing game-changing business opportunities reports with free customization" - so please feel free to provide us with your specific areas of interest / business challenges in much greater detail !!"

We appreciate your interest in this report. Once you fill out the form, you'll be immediately directed to an exclusive solution tailored to your needs. This high-value offering can help boost your revenue by 30% - a must-see opportunity for anyone looking to maximize growth.


By clicking the "Submit" button, you are agreeing to the Terms of Use and Privacy Policy.

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Biopharmaceutical Process Analytical Technology Market

DMCA.com Protection Status